HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Fan Selected Research

Trastuzumab (Herceptin)

7/2021Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial.
1/2021Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
10/2019Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients.
1/2019Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis.
12/2014Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials.
9/2014[Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
5/2014[Efficacy and safety of trastuzumab plus different chemotherapy regimens in treatment of the patients with HER-2-positive advanced breast cancer].
7/2013[Clinical value of trastuzumab in the treatment of lapatinib-resistant HER2-positive metastatic breast cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Fan Research Topics

Disease

58Breast Neoplasms (Breast Cancer)
06/2022 - 12/2008
44Neoplasms (Cancer)
06/2022 - 12/2004
28Triple Negative Breast Neoplasms
01/2022 - 06/2012
20Neoplasm Metastasis (Metastasis)
10/2022 - 01/2010
13Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 11/2008
12Fibrosis (Cirrhosis)
05/2022 - 03/2012
12Gallstones (Gallstone)
05/2021 - 08/2006
10Inflammation (Inflammations)
01/2021 - 01/2010
8Infections
05/2022 - 07/2009
8Disease Progression
10/2021 - 01/2010
7Reperfusion Injury
05/2022 - 05/2008
7Parkinson Disease (Parkinson's Disease)
01/2021 - 08/2009
7Infarction (Infarctions)
01/2019 - 10/2007
6Atrophy
06/2022 - 01/2016
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2010
6Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 04/2009
5Myocardial Infarction
02/2022 - 05/2008
5Body Weight (Weight, Body)
01/2022 - 04/2014
5Hypertension (High Blood Pressure)
03/2021 - 05/2015
4Macular Degeneration (Age-Related Maculopathy)
06/2022 - 08/2015
4Chronic Renal Insufficiency
05/2022 - 04/2005
4Retinal Perforations
04/2022 - 03/2010
4Neutropenia
01/2022 - 10/2015
4COVID-19
11/2021 - 10/2020
4Fever (Fevers)
06/2021 - 09/2012
4Myopia
05/2019 - 06/2011
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 04/2005
4Lymphatic Metastasis
12/2018 - 10/2010
3Adenocarcinoma of Lung
10/2022 - 08/2021
3Acute Kidney Injury (Acute Renal Failure)
05/2022 - 03/2021
3Proteinuria
01/2022 - 01/2017
3Carcinogenesis
01/2022 - 01/2014
3Kidney Diseases (Kidney Disease)
03/2021 - 01/2015
3Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 01/2019
3Necrosis
01/2021 - 01/2019
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 12/2012

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2007
21Biomarkers (Surrogate Marker)IBA
04/2021 - 11/2008
18AnthracyclinesIBA
01/2022 - 01/2010
13Hormones (Hormone)IBA
06/2022 - 01/2011
11CholesterolIBA
01/2022 - 10/2007
11human ERBB2 proteinIBA
02/2021 - 09/2012
11Taxoids (Taxanes)IBA
01/2021 - 01/2010
10ErbB Receptors (EGF Receptor)IBA
10/2022 - 05/2017
10Capecitabine (Xeloda)FDA Link
01/2021 - 01/2010
9Phosphotransferases (Kinase)IBA
05/2022 - 06/2015
9Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 12/2008
8PlatinumIBA
01/2022 - 10/2014
8Trastuzumab (Herceptin)FDA Link
07/2021 - 07/2013
8Retinaldehyde (Retinal)IBA
06/2021 - 03/2012
7Indicators and Reagents (Reagents)IBA
06/2022 - 04/2009
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2012
7Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 06/2012
7Estrogen ReceptorsIBA
10/2021 - 06/2012
7Biological ProductsIBA
01/2021 - 12/2004
7taxaneIBA
01/2020 - 08/2010
6CreatinineIBA
05/2022 - 04/2005
6Carboplatin (JM8)FDA LinkGeneric
01/2022 - 06/2012
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 06/2012
6Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2005
6Pharmaceutical PreparationsIBA
10/2020 - 01/2014
5Phenobarbital (Luminal)FDA Link
02/2022 - 12/2013
5Insulin (Novolin)FDA Link
01/2022 - 01/2010
5Vinorelbine (Navelbine)FDA LinkGeneric
07/2021 - 01/2010
5Aromatase InhibitorsIBA
01/2020 - 01/2011
5LipidsIBA
01/2020 - 04/2014
4EnzymesIBA
05/2022 - 01/2012
4Sirolimus (Rapamycin)FDA Link
05/2022 - 10/2010
4CalciumIBA
01/2022 - 02/2005
4AlbuminsIBA
01/2022 - 03/2016
4Therapeutic UsesIBA
11/2021 - 01/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 04/2009
4Small Interfering RNA (siRNA)IBA
11/2021 - 02/2010
4RNA (Ribonucleic Acid)IBA
04/2021 - 01/2007
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2012
4Leucine (L-Leucine)FDA Link
01/2021 - 01/2018
4CytokinesIBA
01/2021 - 11/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 04/2009
4DNA (Deoxyribonucleic Acid)IBA
09/2017 - 01/2007
4EndotoxinsIBA
08/2009 - 08/2006
3AcidsIBA
05/2022 - 08/2009
3Blood Glucose (Blood Sugar)IBA
01/2022 - 09/2016
3Docetaxel (Taxotere)FDA Link
01/2022 - 06/2012
3Epidermal Growth Factor (EGF)IBA
01/2022 - 10/2019
3Estrogens (Estrogen)FDA Link
04/2021 - 12/2008
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2021 - 01/2011
3C-Reactive ProteinIBA
03/2021 - 05/2012
3InterleukinsIBA
01/2021 - 01/2019
3VaccinesIBA
08/2020 - 07/2008
3Protein Kinases (Protein Kinase)IBA
01/2020 - 03/2012
3TamoxifenFDA LinkGeneric
01/2019 - 01/2018

Therapy/Procedure

34Therapeutics
02/2022 - 01/2010
29Drug Therapy (Chemotherapy)
02/2022 - 10/2010
12Adjuvant Chemotherapy
01/2022 - 06/2012
8Neoadjuvant Therapy
01/2022 - 09/2012
5Splenectomy
01/2019 - 03/2011
4Traction
06/2022 - 08/2015
4Lasers (Laser)
01/2015 - 11/2005
3Radiotherapy
01/2021 - 10/2010
3Length of Stay
01/2021 - 10/2019